Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pandemic Forces FDA To Postpone Phasing Out Product Codes (Again)

Executive Summary

The US agency had initially postponed phasing out NHRIC/NDC codes for Unique Device Identifiers until September 2021 after stakeholders argued for more time. Now the deadline has been delayed again – until September 2023 – thanks to the COVID-19 pandemic.

You may also be interested in...



FDA Guidance: Industry May Use Legacy Codes Until 2021

A final guidance document issued Aug. 30 will allow manufacturers to keep using legacy codes, such as National Health Related Item Codes and National Drug Code numbers, until Sept. 24, 2021. The agency previously indicated all legacy codes should be removed from device packaging by Sept. 24, 2018, at the latest.

Verily’s Study Watch Rejected By FDA As Parkinson’s Drug-Development Tool

US regulators say Verily’s Study Watch – meant to be used in Parkinson’s trials – doesn’t collect data needed to assess whether a patient is truly benefitting from a drug.

FDA Says SBOMs Are Key To Better Cybersecurity In NIST Report

The US regulator’s report is meant to help develop new federal cybersecurity purchasing guidelines that could eventually be used to implement a cybersecurity consumer labeling program.

Topics

UsernamePublicRestriction

Register

MT143956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel